Home › Funds › Venrock Adviser, LLC › KRRO

Venrock Adviser, LLC position in KRRO

KORRO BIO INC · Health Care

Venrock Adviser, LLC reported holding 443,431 shares of KRRO (KORRO BIO INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 0.21% of its reported portfolio and ranking #31 among its reported holdings. Venrock Adviser, LLC has disclosed KRRO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)443.43K sh
Reported value held$4.39M
Portfolio Weight0.21%
First reportedQ1 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's KRRO position evolved

Venrock Adviser, LLC first disclosed a stake in KRRO in Q1 2026 at 1,009,500 shares (US$11.4M). The position peaked in Q2 2026 at 1,009,500 shares, worth US$13.3M. Across 3 filings, Venrock Adviser, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 443,431 shares valued at US$4.4M — a reduction of -566,069 shares quarter over quarter.. Notable position changes include a 56% trim in Q3 2026 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.01M $11.43M New
Q2 2026 1.01M $13.31M Hold
Q3 2026 443.43K $4.39M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRRO and 13F data

KRRO (KORRO BIO INC) is a Health Care company. 30 other funds we track also report a position in KRRO — the largest reported positions include Lynx1 Capital Management LP (US$15.3M), NEA Management Company, LLC (US$12.9M), Atlas Venture Life Science Advisors, LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRRO

All KRRO fund holders →

FAQ

How long has Venrock Adviser, LLC held KRRO?

Venrock Adviser, LLC has disclosed KRRO holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Venrock Adviser, LLC's current position in KRRO?

As of Q3 2026, Venrock Adviser, LLC holds 443.43K shares of KRRO (KORRO BIO INC), valued at $4.39M, representing 0.21% of its reported portfolio and ranking #31.

Has Venrock Adviser, LLC been buying or selling KRRO?

In the latest 13F filing (Q3 2026), Venrock Adviser, LLC reduced its position in KRRO. The position peaked in Q2 2026 at 1.01M shares.

Which other funds hold KRRO?

Other major institutional holders of KRRO include Lynx1 Capital Management LP, NEA Management Company, LLC, Atlas Venture Life Science Advisors, LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.